Drug investment to create new product brand is the key

Today's brand means network, brand means value, brand means market, brand means value added, brand means the future, non-branded companies are in fact not competitive, and are bound to decline. The construction of pharmaceutical investment promotion brands should become the eternal pursuit of the operation of pharmaceutical investment enterprises. The effective establishment of investment promotion brands is conducive to the sustained and healthy development of enterprises, the continuous introduction of new products for enterprises, the continuous consolidation of corporate market networks, and the continuous increase in sales of enterprises. Has an irreplaceable role.

In addition, medical agent experts said that for the emergence of new products, the operation of the new market mechanism and the competitors from scratch, from weak to strong, are dynamic markets, so we must make it clear that in the pharmaceutical investment enterprises can Relying on the commonality of products, they quickly occupy the market. After all, consumers have little selectivity. However, when other brands enter the same category, they will encounter competitors. As the product lacks individuality, it will become exhausted and unable to sell. .

In the pharmaceutical investment industry, it has now entered a new investment market environment for pharmaceuticals, large regional and large circulation is inevitable, coupled with the state's pharmaceutical supervision and market regulation, the days of investment drug companies are not better than before, brilliant achievements in the model and process Changes have now taken place. The current target market focus is to subdivide further into the segmented pharmaceutical investment market, subdivide the existing market segment into multiple business segments, and then base on the company’s resources, market marketing environment, and corporate stage goals. Further consider the further divided target market or marketing path to find the best breakthrough business block.

Pharmaceutical investment promotion companies do not have the ownership of products, and the introduction of products often has great limitations. In spite of this, pharmaceutical investment promotion companies should still cooperate with pharmaceutical investment brand manufacturing companies in the context of mature resources and conditions, and introduce branded products. This will not only be attractive to agents, but also be well differentiated from other investment enterprises. Of course, this kind of product introduction can be a brand product group composed of selected products of a national brand manufacturer, or it can be a kind of product packaging cooperation for a pharmaceutical investment brand manufacturer.

Experts in pharmaceutical agents believe that in the premise of a good product, investment promotion companies need to change their concepts: from valuing prices to value, from paying attention to channels to valuing terminals, from paying attention to sales to paying attention to the market, and paying attention to benefits to academics. Drug investment brand from the emphasis on value to value. Consumers are not afraid to buy expensive goods, but they are afraid to buy expensive products; they do not want to buy cheap products, but want to take advantage of them. Therefore, the focus of pharmaceutical investment promotion companies is not to lower prices, but to increase value, so that the value of products is the long-term way.